Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Horrible management

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jul 09, 2024 5:34pm

209 Views

Post# 36125202

RE:Horrible management

SleepyHoward wrote: What about the financial situation howard.
You should work sometimes in the Office to inform the shareholders

I'll drag another one in here because their performance is similar. ROI is not unlike SBM. Management seems to be comfortable in their cash flow. It's a comfortable life - don't see a need for change. If it ain't broke (from their perspective) why fix it!

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3